Correlation between Prolactin Serum with Neutrophil Lymphocyte Ratio (NLR)  in Systemic Inflammatory Response Syndrome by Retnoningrum, Dwi et al.
Published by Universitas Diponegoro. 
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 









Correlation between Prolactin Serum with Neutrophil 
Lymphocyte Ratio (NLR) in Systemic Inflammatory Response 
Syndrome 
 
Dwi Retnoningrum1*, Meita Hendrianingtyas1, Hermawan Istiadi2, Ardhea Jaludamascena3 
 
1Department of Clinical Pathology. Faculty of Medicine. Diponegoro University /  
Diponegoro National Hospital, Indonesia 
2Department of Anatomical Pathology, Faculty of Medicine Diponegoro University, Indonesia 
























Accepted 0 8 -12-2020 
Available online 10-03-2021 
ABSTRACT 
Background: Systemic inflammatory response syndrome (SIRS) is a state of 
systemic inflammatory activation by various causes. SIRS have a high mortality rate. 
Prolactin is known to regulate cellular function of immune system.  Neutrophil-
lymphocyte ratio (NLR) is simple, cost effective and easy parameter that currently 
used as inflammation marker. 
Objective: The aims of this study is to determine the correlation between prolactin 
serum with NLR in SIRS patients. 
Methods: A cross sectional study was conducted on 50 clinically SIRS patients. 
Prolactin serum was measured by enzyme linked immunosorbent assay (ELISA) and 
NLR was calculated manually from absolute neutrophil and lymphocyte count 
measured by automatic hematology analyzer. Non-parametric Spearman test was 
used to analyze the correlation between prolactin with NLR 
Results: Median value of serum prolactin level was 11.32 ng/mL (2.76-194.81), 
whereas the mean value NLR was 16.36 ± 11.58. The correlation between prolactin 
levels with NLR was r = 0.345, p = 0.014. 
Conclusion: There is a weak positive significant correlation between prolactin with 
neutrophil lymphocyte ratio in SIRS 
 
 






Systemic inflammatory response syndrome 
(SIRS) state is systemic activation with multiple 
underlying causes. It has a high risk of sepsis and 
death1.   Septic patients are generally admitted to the 
ICU for long periods of up to 2-3 weeks. 
Antimicrobial agents and advanced life support have 
been used, but the case fatality rate of septic patients 
has been between 20-30% over the past two 
decades.2 The incidence of sepsis in Europe is 
estimated to be 54-116 cases in 100,000 populations 
per year.3 Systemic inflammatory response 
syndrome (SIRS) is characterized by two or more 
symptoms: body temperature >38 °C or <36 °C; 
tachycardia >90 beats/minute; respiratory rate >20 
breaths/ minute or PaCO2 <4.3 kPa (32mmHg); 
leukocyte count >12,000/mm3 or <4000/mm3 or 
>10% immature neutrophils (band).1,2 The 
prevalence of SIRS is very high, covering one-third 
of total hospitalized patients and >50% of intensive 
care unit (ICU) patients. In surgical ICU, SIRS can 
cover > 80% of patients. The prevalence of infection 
increases with the number of SIRS criteria met and 
the severity of the symptoms of sepsis increases.4 
The state of SIRS or sepsis can affect 
Hypothalamic-Pituitary-Adrenal (HPA) axis 
associated with inflammation. Early release of 
cytokines from immune cells plays a role in body 
homeostasis by acting as paracrine, autocrine and 
endocrine with increased release of ACTH hormone  
(adrenocorticotropic hormone), growth hormone 
and prolactin hormone at the onset of sepsis5,6  
Animal studies have shown that prolactin is 
associated with decreased survival and changes in  
the immune system.7 Prolactin plays a role in 
stimulating phagocytosis in several infectious 
microorganisms.
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In addition, prolactin also modulates leukocyte 
adhesion to the endothelium.8  
The neutrophil-lymphocyte ratio (NLR) is an 
inexpensive and easy parameter of routine blood 
tests. Current use of NLR as a marker of 
inflammation has a good correlation with C-reactive 
protein (CRP).9 Holub et al (2012) concluded that an 
NLR with a cut-off of 6.2 has a sensitivity of 91% 
and a specificity of 96% for bacteremia patients.10 A 
study by Jager et al (2010) showed that NLR can be 
a predictor of bacteremia in emergency room 
patients.11 
2. Method 
The cross-sectional study was conducted in 
April-August 2016. The subjects were male, 
according to the SIRS criteria, age more than 18 
years. Patients with autoimmune disease, 
domperidone and bromocriptine therapy were not 
included in this study. Serum prolactin hormone were 
examined by ELISA method. The reference value for 
male was 3-14.7 ng/mL, NLR value was obtained 
from the absolute number of neutrophils divided by 
absolute number of lymphocytes obtained from the 
automatic haematology analyzer. Data were 
presented in the form of mean ± standard deviation 
for numerical data with normal distribution, median 
(minimum-maximum) for abnormal distribution data. 
Data were analyzed using the Spearman correlation 
test to determine the correlation between serum 
prolactin level and NLR. 
3. Results 
Fifty (50) subjects were included in this study. 
The research characteristics can be seen in table 1. 
The data normality test results of NLR obtained 
normal distribution, but the prolactin result were not 
normal distribution so that the correlation test is done 
using Spearman Correlation test. The results of the 
Spearman correlation test analysis showed that there 
was a weak correlation between prolactin with NLR 




Tabel 1. Baseline characteristics in subjects 
Parameter Mean ±SD Median (min-max) p* 
Age (years) 49.9 ± 13.9 55.5 (18-77) 0.00 
Hemoglobin (mg/dL) 12.4 ± 2.3 12.8 (7.4 -16.3) 0.20 
Leukocyte count (/µL) 16,965 ±6,749 16,150 (3,100-38,500) 0.01 
Neutrophil (/µL) 14,635 ± 6,238 13,800 (2,490 – 35,000) 0.06 
Lymphocyte (/µL) 1,287 ± 799 985 (200-3,300) 0.01 
Platelet (/µL) 253,362 ± 109,280 239,500 (84,400-617,000) 0.20 
NLR 16.37±11.58 14.8 (1.5-54.46) 0.11 
Prolactin (ng/mL) 25.77 ± 38.6   11.32 (2.76-194.81) 0.00 
*p= Kolmogorov Smirnov 
 
 
 Figure 1. Scatter plot of the correlation between serum prolactin and NLR 
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The mean age of the subjects of this study was 
49.9 ± 13.85 years, with an age range between 18-77 
years, median value of 55.5 years, these results are in 
accordance with the study of Kofoed et al. with 
median age was 56 year (range 20-94 years).12  
According to the study of Comstedt et al, SIRS 
occurred at the age of 15-96 years, whereas Lai et al, 
SIRS occurred at a mean age of 62 ± 17 years.13,14 The 
results of the Spearman correlation test analysis 
showed that there was a weak correlation between 
serum prolactin levels and NLR (r = 0.345, p = 
0.014). Study of Tuyan et al., reported a correlation 
between NLR and prolactin levels in infertility 
patients (r = 0.409, p = 0.043).15  
The main biological function of prolactin 
hormone known so far is a lactation hormone. Some 
evidence suggests that the prolactin hormone is a 
growth factor for lymphocyte and stimulates an 
immune response. Prolactin is also produced by 
immune system cells, such as macrophages, NK 
cells, T lymphocytes and B lymphocytes. In addition, 
almost all hematopoietic cells have prolactin 
receptors on their cell surface.16,17 Increased levels of 
the prolactin hormone can cause changes in the state 
of immunity in pathological conditions. 
Hyperprolactinemia has been reported to occur in 
several autoimmune diseases such as systemic lupus 
erythematosus (SLE), rheumatoid arthritis, and 
systemic sclerosis. The effect of the prolactin 
hormone on pancreatic beta cells, liver, T 
lymphocytes is to regulate cell proliferation, while in 
the prostate, lymphocytes, ovarian carcinoma cells, 
breast carcinoma cells and others, prolactin acts as an 
anti-apoptosis factor.16,18,19 Prolactin regulates the 
functions of proliferation, differentiation, 
angiogenesis and protection from apoptosis and 
inflammation. The action of prolactin begins with 
binding to specific membrane receptors, where 
prolactin receptors are present in immune cells and 
are included in cytokine receptors such as IL-2, IL-3, 
IL-4, IL-6, IL-7 receptors, growth hormone and 
erythropoietin.15 Prolactin acts as a pro-inflammatory 
cytokine by increasing the production of IFN-c, IL-
12, and IL-1b in peritoneal macrophages.20 Prolactin 
also increase the production of IFN-c and TNF-α in 
T cells and mononuclear cells.21  
During inflammatory conditions prolactin has 
been described as inducing phagocytosis, although 
the mechanism by which prolactin regulates 
phagocytosis is unknown and induces release of pro-
inflammatory cytokines. Immunomodulation of 
prolactin appears to be an increase in transcription 
factors such as IRF and NF-κB which play a role in 
immune function.22  Brand et al (2004), have shown 
that prolactin increases the release of TNF-α and IL-
2 from mononuclear cells by stimulation of LPS 
(lipopolysaccharide). TNF-α and IL-2 are important 
cytokines as mediators of inflammation, 
complications of sepsis and autoimmunity.23 
There were several limitations of this study. This 
study did not exclude the presence of psychological 
stress that can increase prolactin levels. This study 
also did not measure the pro-inflammatory cytokines 
that play a role in the pathophysiology of SIRS. 
5. Conclusion 
There is a weak positive significant correlation 
between prolactin with neutrophil lymphocyte ratio 
in systemic inflammatory response syndrome. 
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